Boston Financial Mangement LLC Boosts Stake in UnitedHealth Group Incorporated (UNH)

Boston Financial Mangement LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 111,535 shares of the healthcare conglomerate’s stock after buying an additional 4,519 shares during the quarter. UnitedHealth Group comprises 1.5% of Boston Financial Mangement LLC’s portfolio, making the stock its 8th biggest position. Boston Financial Mangement LLC’s holdings in UnitedHealth Group were worth $20,681,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Honeywell International Inc. acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $35,262,000. Harwood Advisory Group LLC grew its position in shares of UnitedHealth Group by 0.8% during the 1st quarter. Harwood Advisory Group LLC now owns 1,885 shares of the healthcare conglomerate’s stock worth $309,000 after buying an additional 15 shares during the period. Mn Services Vermogensbeheer B.V. grew its position in shares of UnitedHealth Group by 3.9% during the 1st quarter. Mn Services Vermogensbeheer B.V. now owns 25,730 shares of the healthcare conglomerate’s stock worth $3,946,000 after buying an additional 970 shares during the period. Suntrust Banks Inc. grew its position in shares of UnitedHealth Group by 8.5% during the 1st quarter. Suntrust Banks Inc. now owns 260,811 shares of the healthcare conglomerate’s stock worth $42,774,000 after buying an additional 20,541 shares during the period. Finally, Abner Herrman & Brock LLC grew its position in shares of UnitedHealth Group by 7.4% during the 1st quarter. Abner Herrman & Brock LLC now owns 30,511 shares of the healthcare conglomerate’s stock worth $5,004,000 after buying an additional 2,098 shares during the period. Institutional investors own 86.21% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This article was first published by Stock Observer and is the sole property of of Stock Observer. If you are viewing this article on another site, it was illegally copied and reposted in violation of U.S. & international copyright & trademark laws. The original version of this article can be viewed at https://www.thestockobserver.com/2017/09/13/boston-financial-mangement-llc-boosts-stake-in-unitedhealth-group-incorporated-unh.html.

In related news, Director Richard T. Burke sold 15,000 shares of UnitedHealth Group stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the transaction, the director now owns 1,818,898 shares of the company’s stock, valued at $348,700,935.58. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction that occurred on Tuesday, September 5th. The shares were sold at an average price of $199.49, for a total value of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares in the company, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 25,600 shares of company stock worth $4,962,694. 0.89% of the stock is owned by insiders.

Several equities analysts recently issued reports on UNH shares. UBS AG reiterated an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price objective for the company in a research report on Tuesday, May 30th. BidaskClub upgraded UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, July 8th. Morgan Stanley boosted their price objective on UnitedHealth Group from $202.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, June 28th. Finally, Vetr upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective for the company in a research report on Tuesday, May 30th. One analyst has rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $203.41.

Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at 197.47 on Wednesday. The company has a market cap of $190.93 billion, a PE ratio of 23.72 and a beta of 0.63. UnitedHealth Group Incorporated has a 52 week low of $132.88 and a 52 week high of $200.44. The stock’s 50 day moving average price is $194.40 and its 200-day moving average price is $179.90.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion for the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. UnitedHealth Group’s quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.96 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post $9.87 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Friday, September 8th will be given a dividend of $0.75 per share. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 35.13%.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply